Outcome measurement in economic evaluations of growth factors.
There are several ways of measuring outcome in an economic evaluation of filgrastim therapy. These measures imply different types of economic evaluation. In all cases, the filgrastim therapy is compared with no filgrastim therapy. Since different therapeutic strategies are connected with uncertain consequences, decision trees are helpful analytical tools. The potential implications of different types of economic evaluations are illustrated with a simple decision tree.
Jönsson
B
B
Centre for Health Economics, Stockholm School of Economics, Sweden.
Karlsson
G
G
D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy; D017063:Outcome Assessment, Health Care; D011788:Quality of Life; D011994:Recombinant Proteins / Q000191:economics; D026712:Value of Life
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor